Captor Therapeutics S.A.
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
CTX | WAR
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
Captor Therapeutics S.A. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel therapeutics using Targeted Protein Degradation (TPD) technology. The company focuses on creating breakthrough, first-in-class treatments for high unmet medical needs, particularly in oncology and autoimmune diseases. Its core is the proprietary Optigrade™ drug discovery platform, which leverages multidisciplinary expertise in protein engineering, structural biology, and molecular modelling. This integrated approach enables the company to address previously "undruggable" molecular targets, accelerating the development of drug candidates with the potential to significantly impact patient outcomes.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-10-24 18:29 |
Regulatory News Service
Zawarcie umowy z Europejską Radą ds. Innowacji i Agencją Wykonawczą ds. MŚP (EI…
|
Polish | 1.3 KB | ||
| 2025-10-22 17:51 |
Post-Annual General Meeting Information
treść uchwał
|
Polish | 465.8 KB | ||
| 2025-10-22 17:51 |
Post-Annual General Meeting Information
Treść uchwał podjętych przez Nadzwyczajne Walne Zgromadzenie 22 października 20…
|
Polish | 1.2 KB | ||
| 2025-10-15 15:25 |
Post-Annual General Meeting Information
projekt uchwały
|
Polish | 167.2 KB | ||
| 2025-10-15 15:25 |
Pre-Annual General Meeting Information
Zgłoszenie przez Akcjonariusza projektu uchwały w sprawie objętej porządkiem ob…
|
Polish | 1.1 KB | ||
| 2025-10-14 18:11 |
Share Issue/Capital Change
Zakończenie subskrypcji akcji serii W emitowanych w związku z realizacją progra…
|
Polish | 4.1 KB | ||
| 2025-09-30 13:20 |
Director's Dealing
załącznik do raportu
|
Polish | 4.3 KB | ||
| 2025-09-30 13:20 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 398 bytes | ||
| 2025-09-30 13:10 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.3 KB | ||
| 2025-09-30 13:10 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 566 bytes | ||
| 2025-09-30 12:53 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.3 KB | ||
| 2025-09-30 12:53 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 543 bytes | ||
| 2025-09-29 16:32 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.4 KB | ||
| 2025-09-29 16:32 |
Director's Dealing
Informacja o transakcji na akcjach Spółki uzyskana w trybie art. 19 MAR - Conte…
|
Polish | 653 bytes | ||
| 2025-09-29 16:26 |
Director's Dealing
Załącznik do raportu
|
Polish | 4.4 KB |
Automate Your Workflow. Get a real-time feed of all Captor Therapeutics S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Captor Therapeutics S.A.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Captor Therapeutics S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
